Dermata Therapeutics, Inc. DRMA Q2 2025 earnings
Reported August 13, 2025 · Before market open
EPS estimate-$2.90
Next report
Aug 18, 2026 (in a month)EPS estimate-$0.55
Versus estimates
Diluted EPS
Ask the moment Dermata Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Dermata Therapeutics, Inc. report Q2 2025 earnings?
- Dermata Therapeutics, Inc. (DRMA) reported Q2 2025 earnings on August 13, 2025 before market open.
- What were Dermata Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Dermata Therapeutics, Inc. reported diluted EPS of $-1.66 for Q2 2025.
- Did Dermata Therapeutics, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-2.90 by $1.24.
- How did Dermata Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 60.3% from $-4.18.
- Where can I find Dermata Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001641172-25-023572) directly on SEC EDGAR. The filing index links above go to sec.gov.